在不调节TDP-43病理的情况下,CPEB3可以选择性地抑制α-synuclein聚合
Ann Teres Babu1, Mufeeda Farhana A1, Harsha Varthini Periasamy1
1School of Chemistry, Indian Institute of Science Education and Research Thiruvananthapuram (IISER TVM), Thiruvananthapuram, India.
FEBS letters
|February 24, 2026
概括
CPEB3类域1 (PRD1) 选择性地抑制了α-synuclein (α-Syn) 粉样蛋白聚合,这是帕金森病的一个关键因素. 它不会影响TARDNA结合蛋白43 (TDP-43) 的聚合.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 分子生物学分子生物学
背景情况:
- 错误折叠的蛋白质聚合,包括α-synuclein (α-Syn) 和TAR DNA结合蛋白43 (TDP-43),是帕金森氏症和前性痴呆症等神经退行性疾病的核心.
- 异型蛋白质聚合物以其高细胞毒性而闻名.
- 在神经退行性疾病中,α-Syn,TDP-43和tau病理的同时发生很常见.
研究的目的:
- 调查CPEB3的第一个类域 (PRD1) 是否调节α-Syn和TDP-43.3的聚合.
- 为了确定PRD1与α-Syn和TDP-43聚合物的特定相互作用.
主要方法:
- 核磁共振 (NMR) 放松实验以探测直接相互作用.
- 阶段分离试验用于评估液体-液体相分离 (LLPS) 介导的聚合.
- 分析与α-Syn的粉样核和TDP-43 (TDP-43CTD) 的C端域的相互作用.
主要成果:
- PRD1直接与α-Syn的粉样核相互作用,导致抑制聚合.
- 阶段分离试验表明,PRD1延迟了LLPS介导的α-Syn聚合.
- 在PRD1和TDP-43CTD之间没有观察到直接相互作用.
结论:
- CPEB3 PRD1可以选择性地抑制α-Syn聚合.
- PRD1与α-Syn粉样核的相互作用及其对LLPS的影响表明神经保护的特定机制.
- 这些发现凸显了PRD1作为α-Syn相关神经退行性疾病的潜在治疗点.
更多相关视频
09:36Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays
Published on: August 13, 2017
7.1K
09:16Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
Published on: June 26, 2018
8.1K
相关概念视频
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
The Unfolded Protein Response
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
